Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fatal diffuse alveolar damage after gold medication]

U Mack1, K Schmidt, M Heine

  • 1Pathologisches Institut des Klinikum Mannheim, Fakultät für Klinische Medizin Mannheim, Universität Heidelberg.

Pneumologie (Stuttgart, Germany)
|May 1, 1994
PubMed
Summary

Gold therapy for rheumatoid arthritis can cause fatal pulmonary failure, a rare but serious complication. Early diagnosis and steroid treatment are crucial for managing this immune-mediated lung injury.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor necrosis factor-alpha and basic fibroblast growth factor decrease glial fibrillary acidic protein and its encoding mRNA in astrocyte cultures and glioblastoma cells.

Journal of neurochemistry·1995
Same author

Bile-independent absorption of cyclosporine from a microemulsion formulation in liver transplant patients.

Transplantation·1995
Same author

Expression of interleukin-11 and its encoding mRNA by glioblastoma cells.

Neuroscience letters·1995
Same author

Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and L-arginine in the formation of an SDS-resistant dimer.

The EMBO journal·1995
Same author

Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.

Molecular pharmacology·1995
Same author

[Quality comparison of modified neurolept-, balanced and intravenous anesthesia. 1. Study design and patient analysis of the Krefelder study 1992].

Der Anaesthesist·1995

Area of Science:

  • Pulmonology
  • Rheumatology
  • Toxicology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease.
  • Gold compounds have been used to treat RA.
  • Pulmonary complications are a known risk of gold therapy.

Observation:

  • A 74-year-old woman developed severe dyspnea and respiratory failure after gold therapy for RA.
  • Chest imaging revealed progressive infiltrates suggestive of interstitial lung disease.
  • Steroid therapy provided only temporary relief.

Findings:

  • The patient experienced fatal pulmonary failure, characterized by diffuse alveolar damage and pulmonary fibrosis.
  • This case represents the fourth documented fatality linked to gold therapy.
  • Post-mortem findings confirmed diffuse alveolar damage in its proliferative stage.

Related Experiment Videos

Implications:

  • Prompt recognition of gold-induced lung disease is vital.
  • Early discontinuation of gold medication and initiation of steroid therapy can improve outcomes.
  • Understanding the immunological basis of this condition is key for effective intervention.